1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition 18
3.2 Scope Of The Study 18
3.3 List Of Assumptions 19
3.4 Market Structure 19
4 Research Methodology
4.1 Research Process 21
4.2 Primary Research 21
4.3 Secondary Research 22
4.4 Market Size Estimation 23
4.5 Forecast Model 24
5 Market Dynamics
5.1 Introduction 26
5.2 Drivers 26
5.2.1 Increasing Prevalence Of Thyroid Diseases 26
5.2.2 Rising Awareness Of Thyroid 26
5.2.3 Favorable Reimbursement And Funding Policies 27
5.2.4 Drivers Impact Analysis 27
5.3 Restraint 28
5.3.1 High Cost Of Treatment Procedures Such As Radioactive Iodine (RAI) Therapy 28
5.3.2 Side-Effects Related To Available Therapeutics 28
5.3.3 Restraints Impact Analysis 28
5.4 Opportunity 29
5.4.1 Emerging Markets Of Asia-Pacific 29
5.5 Macroeconomic Indicators 29
6 Market Factor Analysis
6.1 Porterโs Five Forces Model 31
6.1.1 Threat Of New Entrants 32
6.1.2 Bargaining Power Of Suppliers 32
6.1.3 Threat Of Substitutes 32
6.1.4 Bargaining Power Of Buyers 32
6.1.5 Intensity Of Rivalry 32
7 Thyroid Disorder Market, By Type
7.1 Overview 34
7.1.1 Introduction 34
7.1.2 Hypothyroidism 35
7.1.3 Hyperthyroidism 36
8 Thyroid Disorder Market, By Treatment
8.1 Overview 38
8.1.1 Introduction 38
8.1.2 Medications 39
8.1.3 Radioactive Iodine Therapy 40
8.1.4 Surgery 41
9 Thyroid Disorder Market, By Route Of Administration
9.1 Overview 43
9.1.1 Oral 44
9.1.2 Intravenous 45
10 Thyroid Disorder Market, By End User
10.1 Overview 47
10.1.1 Hospitals 48
10.1.2 Clinics 49
11 Global Thyroid Disorder Market, By Region
11.1 Overview 51
11.2 Americas 52
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.2.1 North America 55
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.2.1.1 US 57
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.2.1.2 Canada 58
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.2.2 Latin America 60
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3 Europe 62
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.1 Western Europe 64
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.1.1 Germany 66
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.1.2 France 68
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.1.3 UK 69
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.1.4 Italy 71
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.1.5 Spain 73
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.1.6 Rest Of Western Europe 74
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.3.2 Eastern Europe 76
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.4 Asia-Pacific 78
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.4.1 Japan 81
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.4.2 China 82
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.4.3 India 84
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.4.4 South Korea 86
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.4.5 Australia 87
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.4.6 Rest Of Asia-Pacific 89
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.5 Middle East & Africa 91
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.5.1 Middle East 93
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
11.5.2 Africa 95
Thyroid Disorder Market, By Type
Thyroid Disorder Market, By Treatment
Thyroid Disorder Market, By Route Of Administration
Thyroid Disorder Market, By End User
12 Competitive Landscape
12.1 Company Market Share Analysis 98
12.1.1 Introduction 98
13 Company Profiles
13.1 Pfizer Inc 100
13.1.1 Company Overview 100
13.1.2 Financial Overview 100
13.1.3 Products/Services Offered 101
13.1.4 Key Developments 101
13.1.5 SWOT Analysis 101
13.1.6 Key Strategy 101
13.2 Allergan Inc. 102
13.2.1 Company Overview 102
13.2.2 Financial Overview 102
13.2.3 Products/Services Offered 103
13.2.4 Key Developments 103
13.2.5 SWOT Analysis 103
13.2.6 Key Strategy 103
13.3 AbbVie Inc. 104
13.3.1 Company Overview 104
13.3.2 Financial Overview 104
13.3.3 Products/Services Offering 105
13.3.4 Key Developments 105
13.3.5 SWOT Analysis 105
13.3.6 Key Strategy 105
13.4 Merck KGaA 106
13.4.1 Company Overview 106
13.4.2 Financial Overview 106
13.4.3 Products/Services Offering 107
13.4.4 Key Developments 107
13.4.5 SWOT Analysis 107
13.4.6 Key Strategy 107
13.5 RLC Labs 108
13.5.1 Company Overview 108
13.5.2 Financial Overview 108
13.5.3 Products/Services Offered 108
13.5.4 SWOT Analysis 108
13.5.5 Key Developments 108
13.5.6 Key Strategy 108
13.6 Abbott Laboratories 109
13.6.1 Company Overview 109
13.6.2 Financial Overview 109
13.6.3 Products/Services Offered 110
13.6.4 Key Developments 110
13.6.5 SWOT Analysis 110
13.6.6 Key Strategy 110
13.7 GlaxoSmithKline PLC 111
13.7.1 Company Overview 111
13.7.2 Financial Overview 111
13.7.3 Products/Services Offered 112
13.7.4 Key Developments 112
13.7.5 SWOT Analysis 112
13.7.6 Key Strategy 112
13.8 Mylan 113
13.8.1 Company Overview 113
13.8.2 Financial Overview 113
13.8.3 Products/Services Offered 114
13.8.4 Key Developments 114
13.8.5 SWOT Analysis 114
13.8.6 Key Strategy 114
14 Appendix
14.1 Discussion Blue Print 116
15 List Of Tables
TABLE 1 MARKET SYNOPSIS 16
TABLE 2 LIST OF ASSUMPTIONS 19
TABLE 3 GLOBAL THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 35
TABLE 4 GLOBAL THYROID DISORDER MARKET FOR HYPOTHYROIDISM, BY REGION, 2020โ2027 (USD MILLION) 35
TABLE 5 GLOBAL THYROID DISORDER MARKET FOR HYPERTHYROIDISM, BY REGION, 2020โ2027 (USD MILLION) 36
TABLE 6 GLOBAL THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 39
TABLE 7 GLOBAL THYROID DISORDER MARKET FOR MEDICATIONS, BY REGION, 2020โ2027 (USD MILLION) 39
TABLE 8 GLOBAL THYROID DISORDER MARKET FOR RADIOACTIVE IODINE THERAPY, BY REGION, 2020โ2027 (USD MILLION) 40
TABLE 9 GLOBAL THYROID DISORDER MARKET FOR SURGERY, BY REGION, 2020โ2027 (USD MILLION) 41
TABLE 10 GLOBAL THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 44
TABLE 11 GLOBAL THYROID DISORDER MARKET FOR ORAL, BY REGION, 2020โ2027 (USD MILLION) 44
TABLE 12 GLOBAL THYROID DISORDER MARKET FOR INTRAVENOUS, BY REGION, 2020โ2027 (USD MILLION) 45
TABLE 13 GLOBAL THYROID DISORDER MARKET, BY END USER, 2020โ2027 (USD MILLION) 48
TABLE 14 GLOBAL THYROID DISORDER MARKET FOR HOSPITALS, BY REGION, 2020โ2027 (USD MILLION) 48
TABLE 15 GLOBAL THYROID DISORDER MARKET FOR CLINICS, BY REGION, 2020โ2027 (USD MILLION) 49
TABLE 16 GLOBAL THYROID DISORDER MARKET, BY REGION, 2020โ2027 (USD MILLION) 51
TABLE 17 AMERICAS: THYROID DISORDER MARKET, BY REGION, 2020โ2027 (USD MILLION) 53
TABLE 18 AMERICAS: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 53
TABLE 19 AMERICAS: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 54
TABLE 20 AMERICAS: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 54
TABLE 21 AMERICAS: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 54
TABLE 22 NORTH AMERICA: THYROID DISORDER MARKET, BY COUNTRY, 2020โ2027 (USD MILLION) 55
TABLE 23 NORTH AMERICA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 55
TABLE 24 NORTH AMERICA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 55
TABLE 25 NORTH AMERICA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 56
TABLE 26 NORTH AMERICA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 56
TABLE 27 US: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 57
TABLE 28 US: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 57
TABLE 29 US: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 57
TABLE 30 US: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 58
TABLE 31 CANADA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 58
TABLE 32 CANADA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 59
TABLE 33 CANADA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 59
TABLE 34 CANADA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 60
TABLE 35 LATIN AMERICA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 60
TABLE 36 LATIN AMERICA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 60
TABLE 37 LATIN AMERICA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 61
TABLE 38 LATIN AMERICA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 61
TABLE 39 EUROPE: THYROID DISORDER MARKET, BY REGION, 2020โ2027 (USD MILLION) 62
TABLE 40 EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 63
TABLE 41 EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 63
TABLE 42 EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 63
TABLE 43 EUROPE: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 64
TABLE 44 WESTERN EUROPE: THYROID DISORDER MARKET, BY COUNTRY, 2020โ2027 (USD MILLION) 64
TABLE 45 WESTERN EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 65
TABLE 46 WESTERN EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 65
TABLE 47 WESTERN EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 65
TABLE 48 WESTERN EUROPE: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 66
TABLE 49 GERMANY: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 66
TABLE 50 GERMANY: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 67
TABLE 51 GERMANY: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 67
TABLE 52 GERMANY: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 67
TABLE 53 FRANCE: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 68
TABLE 54 FRANCE: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 68
TABLE 55 FRANCE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 69
TABLE 56 FRANCE: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 69
TABLE 57 UK: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 69
TABLE 58 UK: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 70
TABLE 59 UK: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 70
TABLE 60 UK: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 71
TABLE 61 ITALY: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 71
TABLE 62 ITALY: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 72
TABLE 63 ITALY: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 72
TABLE 64 ITALY: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 72
TABLE 65 SPAIN: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 73
TABLE 66 SPAIN: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 73
TABLE 67 SPAIN: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 74
TABLE 68 SPAIN: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 74
TABLE 69 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 74
TABLE 70 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 75
TABLE 71 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 75
TABLE 72 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 76
TABLE 73 EASTERN EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 76
TABLE 74 EASTERN EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 76
TABLE 75 EASTERN EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 77
TABLE 76 EASTERN EUROPE: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 77
TABLE 77 ASIA-PACIFIC: THYROID DISORDER MARKET, BY COUNTRY, 2020โ2027 (USD MILLION) 79
TABLE 78 ASIA-PACIFIC: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 79
TABLE 79 ASIA-PACIFIC: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 80
TABLE 80 ASIA-PACIFIC: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 80
TABLE 81 ASIA-PACIFIC: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 80
TABLE 82 JAPAN: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 81
TABLE 83 JAPAN: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 81
TABLE 84 JAPAN: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 82
TABLE 85 JAPAN: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 82
TABLE 86 CHINA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 82
TABLE 87 CHINA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 83
TABLE 88 CHINA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 83
TABLE 89 CHINA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 84
TABLE 90 INDIA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 84
TABLE 91 INDIA; THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 84
TABLE 92 INDIA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 85
TABLE 93 INDIA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 85
TABLE 94 SOUTH KOREA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 86
TABLE 95 SOUTH KOREA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 86
TABLE 96 SOUTH KOREA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 86
TABLE 97 SOUTH KOREA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 87
TABLE 98 AUSTRALIA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 87
TABLE 99 AUSTRALIA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 88
TABLE 100 AUSTRALIA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 88
TABLE 101 AUSTRALIA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 88
TABLE 102 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 89
TABLE 103 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 89
TABLE 104 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 90
TABLE 105 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 90
TABLE 106 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY REGION, 2020โ2027 (USD MILLION) 91
TABLE 107 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 92
TABLE 108 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 92
TABLE 109 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 92
TABLE 110 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 93
TABLE 111 MIDDLE EAST: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 93
TABLE 112 MIDDLE EAST: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 94
TABLE 113 MIDDLE EAST: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 94
TABLE 114 MIDDLE EAST: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 94
TABLE 115 AFRICA: THYROID DISORDER MARKET, BY TYPE, 2020โ2027 (USD MILLION) 95
TABLE 116 AFRICA: THYROID DISORDER MARKET, BY TREATMENT, 2020โ2027 (USD MILLION) 95
TABLE 117 AFRICA; THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020โ2027 (USD MILLION) 96
TABLE 118 AFRICA: THYROID DISORDER MARKET, BY END USER 2020โ2027 (USD MILLION) 96
16 List Of Figures
FIGURE 1 GLOBAL THYROID DISORDER MARKET: MARKET STRUCTURE 19
FIGURE 2 RESEARCH PROCESS OF MRFR 21
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACHES 24
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL THYROID DISORDER MARKET 26
FIGURE 5 DRIVERS IMPACT ANALYSIS: GLOBAL THYROID DISORDER MARKET 27
FIGURE 6 RESTRAINTS IMPACT ANALYSIS: GLOBAL THYROID DISORDER MARKET 28
FIGURE 7 PORTERโS FIVE FORCES MODEL: GLOBAL THYROID DISORDER MARKET 31
FIGURE 8 GLOBAL THYROID DISORDER MARKET, BY TYPE, 2020 (%) 34
FIGURE 9 GLOBAL THYROID DISORDER MARKET, BY TYPE, 2020 AND 2027 34
FIGURE 10 GLOBAL THYROID DISORDER MARKET, BY TREATMENT, 2020 (%) 38
FIGURE 11 GLOBAL THYROID DISORDER MARKET, BY TREATMENT, 2020 AND 2027 38
FIGURE 12 GLOBAL THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020 (%) 43
FIGURE 13 GLOBAL THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020 AND 2027 43
FIGURE 14 GLOBAL THYROID DISORDER MARKET, BY END USER, 2020 (%) 47
FIGURE 15 GLOBAL THYROID DISORDER MARKET, BY END USER, 2020 AND 2027 47
FIGURE 16 GLOBAL THYROID DISORDER MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 51
FIGURE 17 GLOBAL THYROID DISORDER MARKET, BY REGION, 2020 (%) 52
FIGURE 18 AMERICAS: THYROID DISORDER MARKET SHARE, BY REGION, 2020 (%) 53
FIGURE 19 EUROPE: THYROID DISORDER MARKET SHARE, BY REGION, 2020 (%) 62
FIGURE 20 ASIA-PACIFIC: THYROID DISORDER MARKET SHARE, BY COUNTRY, 2020 (%) 78
FIGURE 21 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET SHARE, BY REGION, 2020 (%) 91
FIGURE 22 GLOBAL THYROID DISORDER MARKET, MARKET SHARE ANALYSIS 2020 (%) 98